tiprankstipranks
Advertisement
Advertisement

American Vanguard Announces Board Realignment and Director Departures

Story Highlights
  • American Vanguard agreed to shrink its board and add an independent director under terms of a new First Lien Term Loan.
  • Three directors chose not to seek re-election in 2026 to enable the board reduction, with no disputes cited for their departures.
  • Looking for the best stocks to buy? Follow the recommendations of top-performing analysts.
American Vanguard Announces Board Realignment and Director Departures

Claim 55% Off TipRanks

American Vanguard ( (AVD) ) has shared an update.

American Vanguard Corporation has amended its governance structure following a First Lien Term Loan agreement that its subsidiary AMVAC Chemical and affiliates entered into with lenders led by Centerbridge Partners, filed on March 19, 2026. Under the terms of that deal, the company agreed to shrink its board from nine to seven directors and add one independent director in consultation with the lenders within 90 days of March 13, 2026.

As part of these changes, on April 10, 2026, directors Scott Baskin, Emer Gunter and Carmen Tiu de Mino informed the board they will not stand for re-election at the 2026 annual shareholders’ meeting, facilitating the planned board downsizing. The company emphasized that their decisions were not due to any disputes or disagreements over operations, policies or practices, signaling an orderly and lender-influenced realignment of board composition rather than a governance conflict.

The most recent analyst rating on (AVD) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on American Vanguard stock, see the AVD Stock Forecast page.

Spark’s Take on AVD Stock

According to Spark, TipRanks’ AI Analyst, AVD is a Neutral.

The score is held down primarily by weakened financial performance (recent losses, higher leverage, and negative free cash flow) and a strongly bearish technical setup with the stock far below key moving averages. The latest earnings call provides a partial offset via improved EBITDA, cost controls, and maintained EBITDA guidance, but valuation support is limited given the negative P/E and no dividend data.

To see Spark’s full report on AVD stock, click here.

More about American Vanguard

American Vanguard Corporation, through its subsidiary AMVAC Chemical Corporation, operates in the chemical industry, focusing on specialized agricultural and commercial chemicals. The company accesses financing from commercial lenders to support its operations and corporate structure, reflecting an active engagement with institutional capital providers.

Average Trading Volume: 340,450

Technical Sentiment Signal: Strong Sell

Current Market Cap: $72.78M

For a thorough assessment of AVD stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1